http://dbpedia.org/ontology/abstract
|
Avicine, tested and developed by AVI BioPh … Avicine, tested and developed by AVI BioPharma, and also known as CTP-37 was trialled as a possible cancer vaccine to treat a number of different cancers. These included colorectal cancer, pancreatic cancer and prostate cancer. The treatment was trialled as and intended to be induced via intramuscular injection into the bloodstream, the location dependent on the treatment area. Common side effects during clinical trials included fever and chills as experienced with many other conventional vaccines. The vaccine operated by eliciting antibodies against human chorionic gonadotropin (hCG) a cancer associated protein expressed by most cancer cells, with the goal of prolonged survival for those affected. Avicine was originated by AVI BioPharma in the USA, who licensed the product to SuperGen. However, due to delays in clinical testing, as a result of research difficulties, the owners of Avicine were forced to direct their attention to other areas being the investigation and treatment of cardiovascular and infectious disease indications.scular and infectious disease indications.
|
http://dbpedia.org/ontology/wikiPageID
|
2857491
|
http://dbpedia.org/ontology/wikiPageLength
|
14417
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1088344996
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Complexity +
, http://dbpedia.org/resource/Cancer_vaccine +
, http://dbpedia.org/resource/Medical_treatment +
, http://dbpedia.org/resource/Pancreatic_cancer +
, http://dbpedia.org/resource/Patient +
, http://dbpedia.org/resource/Formal_charge +
, http://dbpedia.org/resource/Foetus +
, http://dbpedia.org/resource/Immunostimulant +
, http://dbpedia.org/resource/Colorectal_cancer +
, http://dbpedia.org/resource/Gemzar +
, http://dbpedia.org/resource/Phase_II_clinical_research +
, http://dbpedia.org/resource/Category:Vaccines +
, http://dbpedia.org/resource/Route_of_administration +
, http://dbpedia.org/resource/Intramuscular_injection +
, http://dbpedia.org/resource/Cancer_cell +
, http://dbpedia.org/resource/Fever +
, http://dbpedia.org/resource/Chemical_property +
, http://dbpedia.org/resource/Covalent_bond +
, http://dbpedia.org/resource/Diphtheria_toxoid +
, http://dbpedia.org/resource/Pharmaceutical_formulation +
, http://dbpedia.org/resource/Protein +
, http://dbpedia.org/resource/Phases_of_clinical_research +
, http://dbpedia.org/resource/Chemotherapy +
, http://dbpedia.org/resource/Side_effect +
, http://dbpedia.org/resource/Immunological +
, http://dbpedia.org/resource/Epitope +
, http://dbpedia.org/resource/Intention-to-treat_analysis +
, http://dbpedia.org/resource/Median +
, http://dbpedia.org/resource/Pharmacia_&_Upjohn +
, http://dbpedia.org/resource/Monoisotopic_mass +
, http://dbpedia.org/resource/Oncofetal_antigen +
, http://dbpedia.org/resource/Immunomodulator +
, http://dbpedia.org/resource/Antibody +
, http://dbpedia.org/resource/Gemcitabine +
, http://dbpedia.org/resource/Colorectal +
, http://dbpedia.org/resource/Mass_%28mass_spectrometry%29 +
, http://dbpedia.org/resource/Carrier-protein +
, http://dbpedia.org/resource/Stereocenter +
, http://dbpedia.org/resource/Human_chorionic_gonadotropin +
, http://dbpedia.org/resource/Hydrogen_bond +
, http://dbpedia.org/resource/Prostate_cancer +
, http://dbpedia.org/resource/Chills +
, http://dbpedia.org/resource/Drug_class +
, http://dbpedia.org/resource/Phase_I_clinical_research +
, http://dbpedia.org/resource/Canonicalization +
, http://dbpedia.org/resource/Category:Peptide_vaccines +
, http://dbpedia.org/resource/Pregnancy +
, http://dbpedia.org/resource/Safety_profile +
, http://dbpedia.org/resource/Womb +
, http://dbpedia.org/resource/Cancer_linearis +
, http://dbpedia.org/resource/Isotope +
, http://dbpedia.org/resource/Immune_response +
, http://dbpedia.org/resource/Topological_Polar_Surface_Area +
, http://dbpedia.org/resource/Prostate +
, http://dbpedia.org/resource/Peptide_bond +
, http://dbpedia.org/resource/Sarepta_Therapeutics +
, http://dbpedia.org/resource/Category:Cancer_vaccines +
, http://dbpedia.org/resource/Multicenter_trial +
, http://dbpedia.org/resource/Corporate +
, http://dbpedia.org/resource/Cancer +
, http://dbpedia.org/resource/Immune_system +
, http://dbpedia.org/resource/Physical_property +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Molecular-weight +
, http://dbpedia.org/resource/Anatomical_Therapeutic_Chemical_Classification_System +
, http://dbpedia.org/resource/Phase_III_clinical_trials +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Mechanism_of_action +
, http://dbpedia.org/resource/Phase_III_clinical_research +
, http://dbpedia.org/resource/Vaccine +
, http://dbpedia.org/resource/ATC_code +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Cancer_vaccines +
, http://dbpedia.org/resource/Category:Peptide_vaccines +
, http://dbpedia.org/resource/Category:Vaccines +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Avicine?oldid=1088344996&ns=0 +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Avicine +
|
owl:sameAs |
http://dbpedia.org/resource/Avicine +
, http://www.wikidata.org/entity/Q4655047 +
, https://global.dbpedia.org/id/4Jqn2 +
|
rdfs:comment |
Avicine, tested and developed by AVI BioPh … Avicine, tested and developed by AVI BioPharma, and also known as CTP-37 was trialled as a possible cancer vaccine to treat a number of different cancers. These included colorectal cancer, pancreatic cancer and prostate cancer. The treatment was trialled as and intended to be induced via intramuscular injection into the bloodstream, the location dependent on the treatment area. location dependent on the treatment area.
|
rdfs:label |
Avicine
|